Garofalo Elizabeth A.
- SEC CIK
- 0001826361
No open-market purchases or sales filed in the past year.
Current role at each company
- ALEC Alector, Inc.Directoras of Jun 17, 2026
- XENE Xenon Pharmaceuticals Inc.Directoras of Jun 3, 2026
- ACAD Acadia Pharmaceuticals IncDirectoras of Jun 1, 2026
- XCUR Exicure, Inc.Directoras of Jun 15, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Garofalo Elizabeth A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACAD Acadia Pharmaceuticals Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 (view filing) | Sep 2 | 1 day | Garofalo Elizabeth A.Director | SSale | −1.60K | $25.98 | −$41.6K | −5.9%25.4K after | |
| Mar 6, 2025 (view filing) | Mar 5 | 1 day | Garofalo Elizabeth A.Director | SSale | −4.92K | $18.23 | −$89.7K | −21.8%17.6K after |
XENE Xenon Pharmaceuticals Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 (view filing) | Mar 8 | 3 days | Garofalo Elizabeth A.Director | SSale | −2.09K | $45.69 | −$95.6K | −100.0%0 after |